Epidural Stimulation + Resistance Training for Spinal Cord Injury
(REST-SCI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people with spinal cord injuries stand, step, and potentially walk again. It combines epidural stimulation (ES) with resistance training (RT) to improve muscle strength, heart health, and bladder control. The trial compares two groups: one using ES with a special robot suit and RT, and the other using ES with the robot suit but no RT. Suitable candidates have a spinal cord injury at or above the lower back and have knee muscles that respond to stimulation. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to groundbreaking advancements in spinal cord injury recovery.
Will I have to stop taking my current medications?
The trial requires participants to stop taking anti-coagulants or anti-platelet agents, including aspirin, unless they cannot do so for medical reasons.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that epidural stimulation (ES) has been tested in various settings. In studies with animals that have spinal cord injuries, ES improved movement. Human trials demonstrated that ES enhanced trunk stability. These findings suggest that ES is generally well-tolerated.
For resistance training (RT), studies have found significant benefits for people with spinal cord injuries. RT increased muscle strength, improved body composition, and enhanced heart and metabolic health in trials lasting 6 to 12 weeks. This suggests that RT is generally safe for this group.
The trial under consideration is in its later stages (Phase 2/3), indicating that the treatment has already shown some safety in earlier trials. While no treatment is without risk, current evidence supports that both ES and RT are likely to be well-tolerated in humans.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the combination of epidural stimulation (ES) and resistance training (RT) for spinal cord injury because it offers a new approach to rehabilitation. Unlike standard therapies that might focus on physical therapy and medications, this method uses ES to directly stimulate the spinal cord, potentially enhancing the body's ability to regain movement. The integration of resistance training aims to strengthen muscles more effectively by progressively challenging them, either through surface neuromuscular electrical stimulation (NMES) or by using body weight in a sit-to-stand approach. This trial could reveal new insights into improving mobility and muscle function for individuals with spinal cord injuries.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that epidural stimulation (ES) can help people with spinal cord injuries regain movement. In one study, four participants using ES were able to stand independently. Another study found that ES improves trunk stability, which is crucial for mobility. Resistance training (RT) has increased muscle strength and improved heart health in people with spinal cord injuries. RT is also linked to better muscle mass and strength, aiding overall recovery. This trial will compare two approaches: one group will receive a combination of exoskeletal-assisted walking, ES, and RT, while another group will receive exoskeletal-assisted walking with delayed ES and no RT. Together, ES and RT offer promising benefits for improving movement and health in those with spinal cord injuries.14567
Who Is on the Research Team?
Ashraf S Gorgey, PhD
Principal Investigator
Virginia Commonwealth University
Are You a Good Fit for This Trial?
This trial is for adults aged 18-60 with traumatic motor complete spinal cord injury (SCI) at T10 level or above. They must have intact neural circuitry below the SCI as confirmed by tests, and fit specific criteria like having certain muscle responses. People with severe bone density loss, unhealed fractures, major cardiovascular issues, untreated severe spasticity or pressure sores, among other exclusions, cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants undergo 6 months of exoskeletal assisted walking with epidural stimulation (EAW+ES) 3 times per week
Extended Treatment
Participants continue with 6 months of EAW+ES and add resistance training (RT) twice weekly
Follow-up
Participants are monitored for safety and effectiveness after treatment, including changes in EMG patterns, walking speed, and other health metrics
What Are the Treatments Tested in This Trial?
Interventions
- Epidural Stimulation
- Exoskeletal assisted walking
- Resistance Training
Epidural Stimulation is already approved in United States, Canada, European Union for the following indications:
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
Find a Clinic Near You
Who Is Running the Clinical Trial?
United States Department of Defense
Lead Sponsor
Central Virginia VA Health Care System
Collaborator